InvestorsHub Logo
Followers 39
Posts 1575
Boards Moderated 0
Alias Born 02/26/2013

Re: None

Sunday, 01/22/2017 9:18:26 AM

Sunday, January 22, 2017 9:18:26 AM

Post# of 255602
I am trying to get up to speed and have some questions for the board:

Steve Berman is the CEO of On4 Correct?

https://www.linkedin.com/in/steve-berman-4212b21a

On4 is a holdings company with an aggressive focus of acquiring proven and profitable businesses. Our first project is focusing on businesses operating in the $1.7 trillion U.S. healthcare industry. Our newest targeted businesses are operating in the trillion dollar mobile App space. Our first acquisition in the mobile App space is FMS Marketing a global creator and distributor of mobile Apps for Android and Iphones. We are also targeting businesses to acquire and joint venture with in the medical marijuana and emerging MJ ancillary products space.

Linkedin still has him associated with Protext Mobility as well.

Protext Mobility CEO Steve Berman Discusses Distracted Driving, Texting Teens Causing Fatalities, on Nationally Syndicated Radio Show

Is this his connection to FMS App?


http://www.marketwired.com/press-release/protext-mobility-ceo-steve-berman-discusses-distracted-driving-texting-teens-causing-pinksheets-txtm-1948690.htm

Protext Mobility is also traded on OTC under Ticker TXTM
http://investorshub.advfn.com/ProText-Mobility-Inc-TXTM-9720/

TXTM just recently acquired Plandai Biotechnology! MJ Connection????


Plandai Biotechnology South Africa (pty) Ltd, recently acquired by Protext Mobility, Inc, is publicly traded on the OTC Markets under the ticker symbol "TXTM"

The Company is actively engaged in the research and clinical testing of “bioceutical” products—all natural ingredients formulated for pharmaceutical applications and processed under pharma-grade conditions. Our initial product, Phytofare® Catechin Complex, has been clinically proven to have 10 times greater bioavailability over generic catechin extracts. Commencing early 2017, we will be conducting a human clinical trial to determine the effectiveness of Phytofare® in regulating blood sugar levels in diabetics. The trial will be conducted in the island country of Mauritius which has the highest per capita incidence of diabetes in the world. Assuming a favorable result, we anticipate having a product market ready by the end of 2017 and eventually filing for product claims with the US Food and Drug Administration.

My question to the board is how is Steve Berman connected to the TXTM/Plandai and to this statement he made:
Protext Mobility CEO Steve Berman Discusses Distracted Driving, Texting Teens Causing Fatalities, on Nationally Syndicated Radio Show

ONCI
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCI News